106-LB: Real-Life Efficacy and Safety of IDegLira in Type 2 Diabetic Patients during COVID-19: A 6-Month Follow-Up by Teleconsultation in Bucaramanga, Colombia

Objective: Determine impact of degludec / liraglutide (ideglira) on HBA1c, fasting glucose, total daily insulin dose (TDID), hypoglycemia in adults with type II Diabetes Mellitus (T2DM), during covid-19 and follow-up by teleconsultation Methods: Secondary analysis of an anonymized database of sixty...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser:	PARRA SERRANO, GUSTAVO A., TORRESLANGHAMMER, MARIA PAULA, SERRANOGOMEZ, SERGIO, PINTOARIAS, ANDREA J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Coronaviruses COVID-19 Diabetes Diabetes mellitus Dosage Fasting Glucose Hypoglycemia Insulin Patients Statistical analysis Titration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!